GlassScriptPhysician profile
Copper K Newman
NPI 1487620787
$3,486.21
in general payments reported to CMS, 2019-2025
33 companies · $631 in 2025
The $631 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $353 · 2020: $24.40 · 2021: $50.08 · 2022: $790 · 2023: $921 · 2024: $716 · 2025: $631.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,255 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,254.82 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $478.62 | 2019-2025 | Veozah, Myrbetriq |
| Sage Therapeutics, LLC | $430.25 | 2023-2025 | Zurzuvae |
| Abbvie INC. | $296.51 | 2019-2023 | |
| Exeltis, USA INC. | $236.15 | 2022-2025 | Slynd |
| Sumitomo Pharma America, INC. | $233.44 | 2023-2024 | Myfembree |
| Aspira Women'S Health INC | $224.10 | 2022-2023 | Ova1 |
| Mayne Pharma Commercial LLC | $182.04 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $162.92 | 2019-2025 | |
| Pfizer INC. | $142.06 | 2022-2025 | |
| Myovant Sciences INC. | $121.99 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $110.59 | 2022 | |
| Supernus Pharmaceuticals, INC. | $95.12 | 2025 | Qelbree |
| Hologic Sales and Service, LLC | $82.90 | 2024-2025 | Myosure Tissue Removal Device, Novasure, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Channel Medsystems, INC. | $82.82 | 2023 | |
| Daiichi Sankyo INC. | $81.98 | 2019-2023 | Injectafer |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $67.08 | 2019-2023 | Gardasil 9 |
| Therapeuticsmd, INC. | $58.29 | 2019-2022 | |
| Avion Pharmaceuticals | $57.75 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $49.69 | 2020-2021 | |
| Allergan, INC. | $41.21 | 2019 | |
| Alexion Pharmaceuticals, INC. | $35.72 | 2022 | |
| Organon LLC | $33.28 | 2023-2024 | |
| Ascend Therapeutics US, LLC | $24.07 | 2024 | |
| Millicent US INC | $23.50 | 2025 | Intrarosa |
| Teva Pharmaceuticals USA, INC. | $21.14 | 2019 | |
| Lupin INC. | $20.86 | 2019 | |
| Becton, Dickinson and Company | $16.14 | 2019 | |
| Amgen INC. | $13.89 | 2024 | |
| Axonics, INC. | $13.83 | 2022 | |
| Coopersurgical, INC. | $13.54 | 2019 | |
| Scynexis, INC. | $12.72 | 2022 | |
| Mylan Pharmaceuticals INC. | $11.27 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $10.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Copper Newman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.